Source-grounded facts extracted from AEMETIS, INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
AEMETIS, INC reported the three months ended March 31, 2026 results: revenue $54.6 million, net income $21.7 million.
“investors@aemetis.com Aemetis Reports First Quarter 2026 Financial Results Revenue Growth of 27%, Positive Gross Profit, and Increased Dairy RNG Production • Revenues of $54.6 million, an increase of 27% over Q1 2025, with growth across California Ethanol, Dairy RNG, and India Biodiesel segments • Gross profit of $2.8 million, compared with a gross loss of”
AEMETIS, INC dismissed RSM US LLP as its auditor.
“(the “Company”) approved the engagement of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm, beginning with the review of the Company’s financial statements for the quarter ending March 31, 2026, and including the audit of the Company’s consolidated financial statements for the fiscal year ending December 31, 2026.”
AEMETIS, INC engaged KPMG LLP as its auditor.
“(the “Company”) approved the engagement of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm, beginning with the review of the Company’s financial statements for the quarter ending March 31, 2026, and including the audit of the Company’s consolidated financial statements for the fiscal year ending December 31, 2026.”
AEMETIS, INC: Increased authorized common stock from 80,000,000 to 140,000,000 shares (effective 2026-02-18).
“On February 18, 2026, Aemetis, Inc. (the "Company") filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company's capital stock from 145,000,000 shares to 205,000,000 shares, which reflects the increase in the number of authorized shares of the Company’s common stock, par value $0.001 per share (the "Common Stock"), from 80,000,000 to 140,000,000 shares.”
AEMETIS, INC amended Eleventh Waiver and Amendment to Series A Preferred Unit Purchase Agreement with Protair-X Technologies Inc. and Third Eye Capital Corporation, as agent valued at $114.7 million (effective 2025-12-31).
“On February 4, 2026, Aemetis Biogas LLC ("ABGL"), a subsidiary of Aemetis, Inc., entered into an agreement, effective as of December 31, 2025, entitled Eleventh Waiver and Amendment to Series A Preferred Unit Purchase Agreement ("PUPA Eleventh Amendment"), with Protair-X Technologies Inc. ("Holder") and Third Eye Capital Corporation, as agent for the Holder.”
AEMETIS, INC reported the three months ended March 31, 2024 results: revenue $72.6 million, net income Net loss was $24.2 million.
“intensity products that replace fossil fuels, today announced its financial results for the three months ended March 31, 2024. “Revenues during the first quarter of 2024 of $72.6 million reflect strong execution by all three of our operating segments with revenues of $36.1 million from California Ethanol, $32.7 million from India Biodiesel and $3.8 million from”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.